Status:
COMPLETED
Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure
Lead Sponsor:
University of Michigan
Conditions:
Respiratory Failure
Eligibility:
All Genders
Brief Summary
There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks ...
Detailed Description
From 2019-2021, there was increased use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. The pri...
Eligibility Criteria
Inclusion
- Patient weighed less than or equal to 10kg at start of ECMO
- Pulmonary support was the indication for ECLS
- Initial cannulation strategy was VV or VA
- The run occurred during the period 2013-2023
Exclusion
- Patient had CDH
- Patient was post-cardiotomy
- Non-conventional initial cannulation strategies were employed, such as
- Central Cannulation (surrogate for inability to achieve peripheral cannulation)
- Veno-veno-arterial ECMO
- Initial cannulation approach reported as "other"
- Patient was transported into or out of ELSO center on ECMO support
- Patient had pre-ECLS Cardiac Arrest
- Patient did not have subsequent ECMO runs in the ELSO registry
Key Trial Info
Start Date :
October 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2023
Estimated Enrollment :
5058 Patients enrolled
Trial Details
Trial ID
NCT06079034
Start Date
October 18 2023
End Date
December 12 2023
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109